Literature DB >> 21305515

Caspase 3 as a therapeutic target for regulation of intervertebral disc degeneration in rabbits.

Hideki Sudo1, Akio Minami.   

Abstract

OBJECTIVE: Although the etiology of intervertebral disc degeneration is poorly understood, one possible approach for its regulation is apoptosis inhibition. This study was undertaken to investigate the antiapoptotic effects of caspase 3 in intervertebral disc degeneration in rabbits.
METHODS: We investigated the effects of caspase 3 small interfering RNA (siRNA) on rabbit nucleus pulposus cells in a serum-starved medium. The effects of direct injection of Alexa Fluor 555-labeled caspase 3 siRNA into the intervertebral disc were also determined in vivo using the rabbit anular needle puncture model.
RESULTS: Rabbit nucleus pulposus cells transfected with caspase 3 siRNA showed a significant decrease in serum-starved apoptotic cells. After local injection of caspase 3 siRNA into intervertebral discs, red fluorescence was observed in the nucleus pulposus upon treatment with Alexa Fluor 555-labeled caspase 3 siRNA. Caspase 3 messenger RNA and protein were down-regulated in the caspase 3 siRNA group. Magnetic resonance imaging and histologic evaluation showed that degenerative changes were significantly suppressed in the caspase 3 siRNA group 4 and 8 weeks after injection. Quantification of TUNEL staining showed that the caspase 3 siRNA group had significantly fewer apoptotic nucleus pulposus cells than the control siRNA group.
CONCLUSION: Our findings indicate that caspase 3 knockdown in rabbit intervertebral disc cells is effective in preventing apoptotic cell death, thus regulating intervertebral disc degeneration.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21305515     DOI: 10.1002/art.30251

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  36 in total

1.  Simvastatin Inhibits IL-1β-Induced Apoptosis and Extracellular Matrix Degradation by Suppressing the NF-kB and MAPK Pathways in Nucleus Pulposus Cells.

Authors:  Ji Tu; Wentian Li; Yukun Zhang; Xinghuo Wu; Yu Song; Liang Kang; Wei Liu; Kun Wang; Shuai Li; Wenbin Hua; Cao Yang
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

2.  Pyrroloquinoline quinone protects nucleus pulposus cells from hydrogen peroxide-induced apoptosis by inhibiting the mitochondria-mediated pathway.

Authors:  Lianjun Yang; Zijie Rong; Mingjun Zeng; Yanlin Cao; Xumeng Gong; Lijun Lin; Yong Chen; Wei Cao; Lixin Zhu; Weiren Dong
Journal:  Eur Spine J       Date:  2014-10-28       Impact factor: 3.134

3.  Injectable nanofibrous spongy microspheres for NR4A1 plasmid DNA transfection to reverse fibrotic degeneration and support disc regeneration.

Authors:  Ganjun Feng; Zhanpeng Zhang; Ming Dang; Xiaojin Zhang; Yasmine Doleyres; Yueming Song; Di Chen; Peter X Ma
Journal:  Biomaterials       Date:  2017-03-24       Impact factor: 12.479

Review 4.  Extracellular Vesicles as an Emerging Treatment Option for Intervertebral Disc Degeneration: Therapeutic Potential, Translational Pathways, and Regulatory Considerations.

Authors:  Tyler J DiStefano; Keti Vaso; George Danias; Henry N Chionuma; Jennifer R Weiser; James C Iatridis
Journal:  Adv Healthc Mater       Date:  2021-07-23       Impact factor: 9.933

5.  Expression of silent mating type information regulator 2 homolog 1 and its role in human intervertebral disc cell homeostasis.

Authors:  Zhongying Zhang; Kenichiro Kakutani; Koichiro Maeno; Toru Takada; Takashi Yurube; Minoru Doita; Masahiro Kurosaka; Kotaro Nishida
Journal:  Arthritis Res Ther       Date:  2011-12-08       Impact factor: 5.156

6.  Recombinant human SIRT1 protects against nutrient deprivation-induced mitochondrial apoptosis through autophagy induction in human intervertebral disc nucleus pulposus cells.

Authors:  Shingo Miyazaki; Kenichiro Kakutani; Takashi Yurube; Koichiro Maeno; Toru Takada; Zhongying Zhang; Takuto Kurakawa; Yoshiki Terashima; Masaaki Ito; Takeshi Ueha; Takehiko Matsushita; Ryosuke Kuroda; Masahiro Kurosaka; Kotaro Nishida
Journal:  Arthritis Res Ther       Date:  2015-09-15       Impact factor: 5.156

Review 7.  Animal models of regenerative medicine for biological treatment approaches of degenerative disc diseases.

Authors:  Demissew Shenegelegn Mern; Tanja Walsen; Anja Beierfuß; Claudius Thomé
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-11

8.  Exploratory clinical trial on the safety and capability of dMD-001 in lumbar disc herniation: Study protocol for a first-in-human pilot study.

Authors:  Katsuhisa Yamada; Maeda Kenichiro; Yoichi M Ito; Fujio Inage; Toshiyuki Isoe; Nozomi Yokota; Osamu Sugita; Norihiro Sato; Khin Khin Tha; Norimasa Iwasaki; Teruyo Arato; Hideki Sudo
Journal:  Contemp Clin Trials Commun       Date:  2021-06-29

9.  Global identification of genes related to nutrient deficiency in intervertebral disc cells in an experimental nutrient deprivation model.

Authors:  Hideki Sudo; Katsuhisa Yamada; Koji Iwasaki; Hideaki Higashi; Manabu Ito; Akio Minami; Norimasa Iwasaki
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

10.  Lumbar degenerative disc disease: current and future concepts of diagnosis and management.

Authors:  Fadi Taher; David Essig; Darren R Lebl; Alexander P Hughes; Andrew A Sama; Frank P Cammisa; Federico P Girardi
Journal:  Adv Orthop       Date:  2012-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.